| Literature DB >> 32045429 |
Adolfo Maria Tambella1, Luca Omini2, Anna Rita Attili1, Cecilia Vullo1, Stefano Martin1.
Abstract
A hand-made, radiolucent, custom-designed device having a mobile and a non-mobile platforms was used to objectively quantify the in vivo cranial tibial translation, in order to assess the functional status of cranial-cruciate-ligament (CrCL) in dogs. The hypothesis was that changes in CrCL integrity would result in detectable changes in tibial translation. To validate the diagnostic method, data from injured (PA, n = 32), contralateral (CO, n = 32) and healthy stifles (HE, n = 32) were compared. Normalized tibial translation (ΔN) of each stifle was measured in medio-lateral radiographic projection obtained before and during standard thrust force application, in PA (43.59±12.97%), CO (20.32±6.69%) and HE (12.22±3.77%). Comparing PA with HE and CO (ΔN cut-off value: 29.73%), diagnosis could be issued with very high probability. Comparing HE with CO (ΔN cut-off value: 14.80%), high performance was obtained. The translator device could be a useful tool to objectively quantify the in vivo tibial translation in dogs with CrCL rupture, before surgery and during post-operatory follow-up.Entities:
Mesh:
Year: 2020 PMID: 32045429 PMCID: PMC7012417 DOI: 10.1371/journal.pone.0228621
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Positioning of dog on the translator device during the test (a); medio-lateral radiographic projections of the stifle using the translator device before (b) and during standard force application (c) in order to thrust the tibia cranially. Green vertical lines represent reference lines for measurements. Yellow arrows indicate the distance between reference lines before (D1) and during force application (D2).
Fig 2Flow of participants: STARD diagram.
Summary of the generalized linear mixed model (GLMM) assessing the predictivity of ΔN values considering the “group” as fixed factor and the “ID of the dog” as random factor.
| Groups | Variable | Estimate | Standard Error | |
|---|---|---|---|---|
| -47.63 | 0.005319 | <2e-16 | ||
| 1.873563 | 0.005313 | <2e-16 | ||
| -15.6694 | 4.8733 | 0.00130 | ||
| 0.5249 | 0.1602 | 0.00105 | ||
| -29.006 | 14.685 | 0.0482 | ||
| 2.103 | 1.081 | 0.0516 |
ΔN: normalized tibial translation; PA: pathological stifles; CO: contralateral stifles; HE: healthy stifles.
General summary of the linear mixed model (LMM) considering the “group” and the “presence of DJD” as fixed factor and the “ID of the dog” as random factor.
| Variable | Estimate | Standard Error | |
|---|---|---|---|
| 12.220 | 1.466 | 9.95e-11 | |
| 7.951 | 1.960 | 0.000143 | |
| 40.824 | 2.523 | 2.e-16 | |
| -15.355 | 2.537 | 3.90e-08 |
PA: pathological stifles; CO: contralateral stifles; HE: healthy stifles; DJD: degenerative joint disease.
General summary of the linear model to assess potential within-dog association between joint instability and time since CrCL rupture (chronicity) or the presence of DJD.
| Variable | Estimate | Standard Error | |
|---|---|---|---|
| -5.113 | 2.369 | 0.0691 | |
| -40.165 | 9.940 | <0.001 | |
| 6.078 | 2.478 | 0.0372 |
Time: time in weeks since CrCL rupture; DJD: degenerative joint disease; Time-DJD: interaction Time and DJD.
Fig 3Two-graph ROC curve of the diagnostic sensitivity and specificity as a function of the test result (normalized tibial translation, ΔN, %) showing the ΔN optimal cut-off between HE and CO groups.
Fig 4Boxplots showing the normalized tibial translation (ΔN, %) in groups PA (pathological, canine stifles with naturally occurring uni-lateral CrCL rupture), CO (contralateral stifles of affected dogs) and HE (healthy, canine stifles with intact CrCL); the ends of the whiskers show minimum (Min) and maximum (Max) values of ΔN; boxes show the median, the first and the third quartile (Q1 and Q3 respectively); red dots show the mean; dashed red line represents ΔN cut-off between PA and clinically healthy stifles; dotted green line represents ΔN cut-off between HE and CO groups; * indicates statistically significant differences.
Validity assessment of the translator device.
| Groups under comparison | PA | PA | CO |
|---|---|---|---|
| 0.499876 | 0.411041 | 0.4984901 | |
| 1.0 (0.999, 1) | 0.9375 (0.816, 0.992) | 1.0 (0.905, 1) | |
| 1.0 (0.999, 1) | 1.0 (0.991, 1) | 1.0 (0.910, 1) | |
| 1.0 (0.999, 1) | 1.0 (0.986, 1) | 1.0 (0.985, 1) | |
| 1.0 (0.999, 1) | 0.9412 (0.809, 0.957) | 1.0 (0.985, 1) | |
| 1.0 (0.999, 1.0) | 0.9688 (0.892, 0.996) | 1.0 (0.944, 1.0) | |
| 100 (100, 100) | 94.77 (86.41, 96.88) | 100 (100, 100) | |
ΔN: normalized tibial translation; Prob.: probability; PA: pathological stifles; CO: contralateral stifles; HE: healthy stifles; vs: versus; SE: sensitivity; SP: specificity; PPV: positive predictive value; NPV: negative predictive value; ACC: accuracy; AUC: area under the ROC (receiver-operating characteristic) curve; in brackets: 95% confidence interval.